ASO Visual Abstract: Association Between Adjuvant Therapy and Survival in Resected Pancreatic Ductal Adenocarcinoma After Different Types and Durations of Neoadjuvant Therapy

Ann Surg Oncol. 2025 Jun 4. doi: 10.1245/s10434-025-17570-9. Online ahead of print.

Paul C M Andel^{1

2}, Brady A Campbell³, Joseph R Habib⁴, I Quintus Molenaar⁵, Kelly J Lafaro³, William R Burns 3rd³, Lois A Daamen^{5

6}, John L Cameron³, Christopher L Wolfgang⁴, Richard A Burkhart³, Jin He³, Ammar A Javed^{7

8

9}

¹ Department of Surgery, The NYU Grossman School of Medicine and NYU Langone Health, New York, NY, USA. p.c.m.andel-2@umcutrecht.nl.
² Department of Surgery, Regional Academic Cancer Center Utrecht, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein, Utrecht, The Netherlands. p.c.m.andel-2@umcutrecht.nl.
³ Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
⁴ Department of Surgery, The NYU Grossman School of Medicine and NYU Langone Health, New York, NY, USA.
⁵ Department of Surgery, Regional Academic Cancer Center Utrecht, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein, Utrecht, The Netherlands.
⁶ Imaging Division, UMC Utrecht Cancer Center, Utrecht, The Netherlands.
⁷ Department of Surgery, The NYU Grossman School of Medicine and NYU Langone Health, New York, NY, USA. Ammar.Javed@nyulangone.org.
⁸ Department of Surgery, Amsterdam UMC, Location University of Amsterdam, Amsterdam, The Netherlands. Ammar.Javed@nyulangone.org.
⁹ Cancer Center Amsterdam, Amsterdam, The Netherlands. Ammar.Javed@nyulangone.org.

No abstract available